Skip to content
10-K

Annual Report

AVAI BIO, INC. AVAI

0001740797-25-000038

← back to feed
Filed
Jul 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jul 7, 2025 137.51M sh
Operating Cash Flow FY 2025 · Mar 31, 2025 −$1.16M
Short Term Debt FY 2025 · Mar 31, 2025 $30K
Cash And Equivalents FY 2025 · Mar 31, 2025 $81.05K
Stockholders Equity FY 2025 · Mar 31, 2025 −$1.56M
Current Liabilities FY 2025 · Mar 31, 2025 $1.79M
Total Liabilities FY 2025 · Mar 31, 2025 $1.79M
Current Assets FY 2025 · Mar 31, 2025 $93.13K
Total Assets FY 2025 · Mar 31, 2025 $224.75K
Eps Basic FY 2025 · Mar 31, 2025 −$0.01
Sga Expense FY 2025 · Mar 31, 2025 $762.48K
Net Income FY 2025 · Mar 31, 2025 −$1.14M
Operating Income FY 2025 · Mar 31, 2025 −$1.14M